Reshma Singh

1.4k total citations
21 papers, 673 citations indexed

About

Reshma Singh is a scholar working on Immunology, Biotechnology and Molecular Biology. According to data from OpenAlex, Reshma Singh has authored 21 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Biotechnology and 7 papers in Molecular Biology. Recurrent topics in Reshma Singh's work include Immunotherapy and Immune Responses (10 papers), Cancer Research and Treatments (7 papers) and Listeria monocytogenes in Food Safety (4 papers). Reshma Singh is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Cancer Research and Treatments (7 papers) and Listeria monocytogenes in Food Safety (4 papers). Reshma Singh collaborates with scholars based in United States, Malaysia and Austria. Reshma Singh's co-authors include Yvonne Paterson, Peter Cresswell, Anu Wallecha, A. M. Jamieson, Elizabeth M. Jaffee, John Rothman, Mikayel Mkrtichyan, Rasha Abu Eid, Samir N. Khleif and Robert G. Petit and has published in prestigious journals such as Nature, Science and Blood.

In The Last Decade

Reshma Singh

20 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reshma Singh United States 12 364 275 175 135 106 21 673
Joachim Fensterle Germany 14 341 0.9× 121 0.4× 100 0.6× 202 1.5× 90 0.8× 21 668
Seol Hee Hong South Korea 12 325 0.9× 373 1.4× 129 0.7× 210 1.6× 127 1.2× 18 851
Anu Wallecha United States 18 385 1.1× 477 1.7× 187 1.1× 260 1.9× 288 2.7× 26 1.0k
J M Ruehlmann United States 7 281 0.8× 119 0.4× 119 0.7× 162 1.2× 85 0.8× 8 427
Nuno Viegas Germany 7 213 0.6× 186 0.7× 56 0.3× 72 0.5× 93 0.9× 7 487
Mojca Škoberne United States 14 471 1.3× 90 0.3× 79 0.5× 150 1.1× 47 0.4× 23 718
Teodora Kaltcheva United States 13 191 0.5× 167 0.6× 186 1.1× 145 1.1× 104 1.0× 21 688
Reyes S. Taméz-Guerra Mexico 13 274 0.8× 52 0.2× 138 0.8× 195 1.4× 40 0.4× 29 604
Philippe Slos France 17 287 0.8× 95 0.3× 211 1.2× 370 2.7× 254 2.4× 26 805
Rajendra Kumar Gurumurthy Germany 12 143 0.4× 48 0.2× 105 0.6× 219 1.6× 33 0.3× 19 562

Countries citing papers authored by Reshma Singh

Since Specialization
Citations

This map shows the geographic impact of Reshma Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reshma Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reshma Singh more than expected).

Fields of papers citing papers by Reshma Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reshma Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reshma Singh. The network helps show where Reshma Singh may publish in the future.

Co-authorship network of co-authors of Reshma Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Reshma Singh. A scholar is included among the top collaborators of Reshma Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reshma Singh. Reshma Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Reshma. (2023). Partition and Train to Pakistan. 6(4). 74–79. 1 indexed citations
3.
Singh, Reshma, Rohan Diwanji, Pushpa Jayaraman, et al.. (2020). Abstract A76: Anti IL-1b as a cancer immunotherapy. Cancer Immunology Research. 8(4_Supplement). A76–A76. 1 indexed citations
4.
Kenderian, Saad S., Marco Ruella, Olga Shestova, et al.. (2017). Targeting CLEC12A with Chimeric Antigen Receptor T Cells Can Overcome the Chemotherapy Refractoriness of Leukemia Stem Cells. Biology of Blood and Marrow Transplantation. 23(3). S247–S248. 10 indexed citations
5.
Kenderian, Saad S., Marco Ruella, Olga Shestova, et al.. (2016). Leukemia Stem Cells Are Characterized By CLEC12A Expression and Chemotherapy Refractoriness That Can be Overcome By Targeting with Chimeric Antigen Receptor T Cells. Blood. 128(22). 766–766. 11 indexed citations
6.
Tran, Thai H., Reshma Singh, Jennifer Bordeaux, et al.. (2015). Quantitative Multiplexed Immunohistochemistry Assays for Exploring CAR Modified T Cells and Checkpoint Inhibitors in Lymphoma Trials. Blood. 126(23). 2659–2659. 2 indexed citations
7.
Mkrtichyan, Mikayel, Rasha Abu Eid, Anu Wallecha, et al.. (2013). Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy. Journal for ImmunoTherapy of Cancer. 1(1). 15–15. 56 indexed citations
9.
Wallecha, Anu, et al.. (2012). Lm-LLO-Based Immunotherapies and HPV-Associated Disease. Journal of Oncology. 2012. 1–10. 42 indexed citations
10.
Hannan, Raquibul, Huagang Zhang, Anu Wallecha, et al.. (2012). Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer. Cancer Immunology Immunotherapy. 61(12). 2227–2238. 31 indexed citations
11.
Wallecha, Anu, et al.. (2012). Abstract 5241: Development of a single Listeria monocytogene-based vaccine simultaneously targeting two antigens. Cancer Research. 72(8_Supplement). 5241–5241. 1 indexed citations
12.
Singh, Reshma, et al.. (2012). Treatment with Lm-LLO immunotherapies lead to decreased Tregs and MDSC in the tumor microenvironment (165.12). The Journal of Immunology. 188(1_Supplement). 165.12–165.12. 2 indexed citations
13.
Singh, Reshma & Anu Wallecha. (2011). Cancer immunotherapy using recombinantListeria monocytogenes: Transition from bench to clinic. Human Vaccines. 7(5). 497–505. 28 indexed citations
14.
Singh, Reshma & Peter Cresswell. (2010). Defective Cross-Presentation of Viral Antigens in GILT-Free Mice. Science. 328(5984). 1394–1398. 110 indexed citations
15.
Singh, Reshma, A. M. Jamieson, & Peter Cresswell. (2008). GILT is a critical host factor for Listeria monocytogenes infection. Nature. 455(7217). 1244–1247. 112 indexed citations
16.
Singh, Reshma & Yvonne Paterson. (2007). Immunoediting Sculpts Tumor Epitopes during Immunotherapy. Cancer Research. 67(5). 1887–1892. 41 indexed citations
17.
Singh, Reshma & Yvonne Paterson. (2006). In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccines. Cancer Immunology Immunotherapy. 56(6). 927–938. 41 indexed citations
18.
Singh, Reshma & Yvonne Paterson. (2006). Listeria monocytogenesas a vector for tumor-associated antigens for cancer immunotherapy. Expert Review of Vaccines. 5(4). 541–552. 38 indexed citations
19.
Singh, Reshma & Yvonne Paterson. (2006). Vaccination Strategy Determines the Emergence and Dominance of CD8+ T-Cell Epitopes in a FVB/N Rat HER-2/neuMouse Model of Breast Cancer. Cancer Research. 66(15). 7748–7757. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026